NASDAQ:IDRA
Delisted
Idera Pharmaceuticals Stock News
$4.71
+0 (+0%)
At Close: Apr 19, 2023
Idera Pharmaceuticals Announces Corporate Updates
04:15pm, Tuesday, 18'th May 2021
EXTON, Pa., May 18, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today announced that it will not continue ILLUMINATE-301, the Company's trial
Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
04:10pm, Thursday, 29'th Apr 2021
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (“Idera” or the “Company”) (Nasdaq: IDRA) today reported its financial and operational results for the first quarter
IDRA Stock Price Fell 62%: Why It Happened
01:36am, Monday, 22'nd Mar 2021
The stock price of Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) fell by 62% on March 19. This is why it happened.
Tomslist: The 5 Weirdest Penny Stock Stories of the Week
03:45pm, Friday, 19'th Mar 2021
Even the best penny stocks have their dog days. Here's a celebration of this week's weirdest plays: SNES, IDRA, SOS, TSNPD and HLLPF.
Why Idera Pharmaceuticals Stock Is Crashing Today
11:11am, Friday, 19'th Mar 2021
The company's experimental cancer drug flopped in a late-stage study.
IDRA Stock Price Falls Over 60% Pre-Market: Why It Happened
08:28am, Friday, 19'th Mar 2021
The stock price of Idera Pharmaceuticals Inc (NASDAQ: IDRA) fell by over 60% pre-market. This is why it happened.
Idera Pharmaceuticals Announces Results From ILLUMINATE-301 Trial of Tilsotolimod + Ipilimumab in anti-PD-1 Refractory Advanced Melanoma
04:15pm, Thursday, 18'th Mar 2021
– Objective Response Rate Endpoint Not Met – – Objective Response Rate Endpoint Not Met –
Idera Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update
04:35pm, Monday, 01'st Mar 2021
ILLUMINATE-301 Continues on Track for Data Later this Month ILLUMINATE-301 Continues on Track for Data Later this Month
Idera acquires API developer Apilayer
11:19am, Monday, 18'th Jan 2021
Idera, which develops a range of SQL database tools, has acquired Apilayer, an Austrian startup that develops cloud-based API products.
Idera Pharmaceuticals to Present at Upcoming Conferences
06:02am, Monday, 11'th Jan 2021
EXTON, Pa., Jan. 11, 2021 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) today announced that it will provide a company outlook for 2021 at upcoming conferences.
Idera Pharmaceuticals (IDRA) in Focus: Stock Moves 9.4% Higher
09:47am, Thursday, 17'th Dec 2020
Idera Pharmaceuticals (IDRA) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Idera Pharmaceuticals Announces $5.0 Million in Further Proceeds from Private Placement of up to $20.7 Million
08:05am, Tuesday, 15'th Dec 2020
EXTON, Pa., Dec. 15, 2020 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today announced the closing of a second tranche under its April 7, 2020, securities purchase agreement (the “
Idera Pharmaceuticals Announces Dan Soland to Join as Chief Operating Officer
04:27pm, Tuesday, 17'th Nov 2020
– COO Role is Key to Preparedness for NDA Filing and Commercial Launch – – Clayton Fletcher , Head of Business Development & Strategic Planning , to Retire –
Idera Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
04:36pm, Thursday, 29'th Oct 2020
ILLUMINATE-301 Continues on Track and Beyond Melanoma Strategy Advances ILLUMINATE-301 Continues on Track and Beyond Melanoma Strategy Advances
Imperial Oil Has An Imperial Future (NYSEMKT:IMO)
03:00pm, Saturday, 17'th Oct 2020
Imperial Oil is one of the cheapest and highest quality stocks on the market today. IMO's majority ownership by Exxon Mobil provides it with many advantages.
